Canada - Respiratory System Medicine Use
Since 2014, Canada Respiratory System Medicine Use rose 10.6% year on year. With 56.3 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, the country was ranked number 24 among other countries in Respiratory System Medicine Use. Canada is overtaken by Chile, which was ranked number 23 at 63.3 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Latvia with 51.1 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Norway topped the ranking with 230.3 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, that is a growth of 6% versus 2018. Sweden, Finland and United Kingdom respectively ranked number 2, 3 and 4 in this ranking. Canada recorded the best 5 years average growth at +10.6% per year, while Slovakia witnessed the worst performance at -8.4% per year.
Loading...
Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
---|---|
2019 | 56.30 |
2018 | 55.30 |
2017 | 54.90 |
2016 | 57.20 |
2015 | 34.30 |
How does Canada rank in Respiratory System Medicine Use?
# | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
Norway
|
230 | 2019 | +6.0 % | +3.3 % | View data | |
2 |
#2
Sweden
|
206 | 2019 | +6.1 % | +3.9 % | View data | |
23 |
#23
Chile
|
63 | 2019 | +30.0 % | +7.7 % | View data | |
24 |
#24
Canada
|
56 | 2019 | +1.8 % | +10.6 % | View data | |
25 |
#25
Latvia
|
51 | 2019 | +1.6 % | +0.1 % | View data |